MoneyWorks4Me

The Sales for the quarter ended March 2026 of Rs. 38220.00 million declined by -31.29% from Rs. 55629.00 millions.The Net Loss for the quarter ended March 2026 is Rs. -2194.00 millions as compared to Net Profit of Rs. 12007.00 millions of corresponding quarter ended March 2025A decline of 673.00 millions was observed in the OP in the quarter ended March 2026 from 18574.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 38220.00 55629.00 -31.29 205328.00 231154.00 -11.17 205328.00 231154.00 -11.17
Other Income 5672.00 4144.00 36.87 16896.00 10034.00 68.39 16896.00 10034.00 68.39
PBIDT 673.00 18574.00 -96.38 56070.00 83852.00 -33.13 56070.00 83852.00 -33.13
Interest 543.00 311.00 74.60 1483.00 1099.00 34.94 1483.00 1099.00 34.94
PBDT 130.00 18263.00 -99.29 54587.00 82753.00 -34.04 54587.00 82753.00 -34.04
Depreciation 3185.00 2645.00 20.42 12074.00 10394.00 16.16 12074.00 10394.00 16.16
PBT -3055.00 15618.00 -119.56 42513.00 72359.00 -41.25 42513.00 72359.00 -41.25
TAX -861.00 3611.00 -123.84 10316.00 18865.00 -45.32 10316.00 18865.00 -45.32
Deferred Tax 286.00 -32.00 -993.75 1139.00 960.00 18.65 1139.00 960.00 18.65
PAT -2194.00 12007.00 -118.27 32197.00 53494.00 -39.81 32197.00 53494.00 -39.81
Equity 835.00 834.00 0.12 835.00 834.00 0.12 835.00 834.00 0.12
PBIDTM(%) 1.76 33.39 -94.73 27.31 36.28 -24.72 27.31 36.28 -24.72
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..